Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.Investors Business Daily • 02/06/25
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate UpdatePRNewsWire • 02/05/25
Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock SoaringSeeking Alpha • 02/05/25
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?The Motley Fool • 02/02/25
Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?Zacks Investment Research • 01/30/25
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025PRNewsWire • 01/29/25
Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to KnowZacks Investment Research • 01/21/25
Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert24/7 Wall Street • 01/21/25
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc. - VKTXAccesswire • 01/18/25
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped TodayThe Motley Fool • 01/17/25
NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow DownZacks Investment Research • 01/15/25
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on TuesdayThe Motley Fool • 01/14/25